Royal Bank of Canada’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-5,500
Closed -$402K – 7066
2024
Q3
$402K Hold
5,500
– – ﹤0.01% 4271
2024
Q2
$369K Hold
5,500
– – ﹤0.01% 4251
2024
Q1
$149K Buy
+5,500
New +$154K ﹤0.01% 4930

Other funds holding INSM

Royal Bank of Canada's INSM Position: Q2 2026 in Review

Royal Bank of Canada reduced its Insmed (INSM) stake by 20% in Q2 2026, selling an estimated $12.9M and leaving 416,487 shares worth $44.4M. The position accounts for 0.01% of the portfolio, ranked #1064.

Royal Bank of Canada first reported a position in INSM in Q2 2013 and has held it in 51 quarters since. The position peaked at $195M in Q3 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Royal Bank of Canada held 416,487 shares of Insmed worth $44.4M as of Q2 2026.
  • Royal Bank of Canada sold 106,614 Insmed shares in Q2 2026, an estimated $12.9M.
  • Insmed made up 0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #1064 holding.
  • Royal Bank of Canada first reported a position in Insmed in Q2 2013 and has held it in 51 quarters since.
  • Royal Bank of Canada's Insmed position peaked at $195M in Q3 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.